increased heart rate with glp-1 Retatrutide rate: what the clinical data actually shows Cardiovascular Actions of Incretin-Based Therapies

Many people taking GLP-1 medications experience a slowdown in weight loss after 36 months of consistent results

It also appears to modulate the gastrointestinal side effects of GLP-1 activation, which may explain why tirzepatide is better tolerated despite being more potent

Alternative Treatments Post-GLP-1 Transitioning off GLP-1 medications doesnt mean your journey to better health has to end

doi:10.1210/clinem/dgaa863 25

This comprehensive GLP-1 Travel Guide covers everything you need to know to keep your medication safe, stay compliant with regulations, and maintain your treatment schedule wherever your journey takes you